nutrition
-
October 28, 2020
Pancreatic Cancer: Why Diet Is Important
Pancreatic cancer and nutrition are closely intertwined. Research has shown that diet can help many patients manage the loss of appetite and weight loss that often accompany pancreatic cancer, and good nutrition is linked to better treatment outcomes. Intriguingly, mounting evidence also suggests that specific diets may directly affect the underlying biology of pancreatic tumors and improve the success of pancreatic cancer treatment. Read… Read more »
-
October 8, 2020
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer Bookmark
George Lundberg, MDResearch paper from JAMA Oncology curated by Contributing Editor George Lundberg, MD, who notes:
This study linked coffee consumption with longer survival and lower death rates in advanced colorectal cancer.
.
-
November 12, 2019
Researchers Discover Coffee Drinkers Could Halve their Risk of Liver Cancer Bookmark
George Lundberg, MDArticle from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes:
Association is not causation. Yet, when the numbers are very high indeed, and the differences stark, one had best take them seriously. People in the U.K. who drink coffee are half as likely to develop liver cancer, all known confounders considered.
Go to full article published by Medical Xpress.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
May 21, 2019
Can You Improve Your Response to Certain Immunotherapy Drugs?
Emma Shtivelman, PhDCancer treatments that use a strategy called immune checkpoint blockade (ICB) have entered clinical practice in a big way, with six drugs now approved by the U.S. Food and Drug Administration (FDA) for a variety of cancers. These drugs release “brakes” on the immune system, boosting its ability to kill cancer cells. Specifically, they target the proteins PD-1 or CTLA-4, which are found on… Read more »
-
April 8, 2019
New Study Suggests Diet May Affect Response To Cancer Immunotherapy Drugs Bookmark
Emma Shtivelman, PhDExcerpt:
“People with a type of skin cancer who consumed a high-fiber diet responded better to immunotherapy treatment than those with poorer diets, according to data presented at a media preview of the American Association for Cancer Research (AACR) annual meeting.
“Melanoma is a type of skin cancer which although very treatable if caught early, still kills approximately 9,000 Americans a year, mainly people who are diagnosed a more advanced stage of disease where the cancer has spread to other parts of the body.”
Go to full article published by Forbes on Feb 27, 2019.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
December 12, 2018
Vitamin D and Fish Oils Are Ineffective for Preventing Cancer and Heart Disease Bookmark
Emma Shtivelman, PhDExcerpt:
“In recent years, many Americans have embraced vitamin D and fish oil pills, their enthusiasm fueled by a steady trickle of suggestive research studies linking higher levels of vitamin D with lower rates of cancer and other ills, and fish consumption with reduced heart disease.
“Now a large and rigorous government-funded randomized trial — the only such study of omega-3 fish oils ever carried out in healthy adults, and the largest trial ever done of high-dose vitamin D — has found the supplements do not lower cancer rates in healthy adults. Nor do they reduce the rate of major cardiovascular events, a composite of heart attacks, strokes and deaths from cardiovascular disease. The trial is of the kind considered the gold standard in medicine.”
Go to full article published by The New York Times on Nov 10, 2018.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
October 31, 2018
Might Cancer Be a Metabolic Disease?
With: Thomas N. Seyfried, PhDA Q&A with Thomas N. Seyfried, PhD, Professor of Biology, Boston College Q: As a geneticist, you know that the genomic makeup of cancers recently has captivated much of the scientific community with new knowledge and new treatments. And yet, cancer outcomes remain dismal for many patients. You have written about cancer from a very different perspective. Why do you consider cancer to be… Read more »